TNYA Annual CFO
-$102.07 M
+$2.35 M+2.25%
31 December 2023
Summary:
As of January 23, 2025, TNYA annual cash flow from operations is -$102.07 million, with the most recent change of +$2.35 million (+2.25%) on December 31, 2023. During the last 3 years, it has fallen by -$66.63 million (-187.96%). TNYA annual CFO is now -323.61% below its all-time high of -$24.10 million, reached on December 31, 2019.TNYA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNYA Quarterly CFO
-$19.84 M
+$3.78 M+16.01%
30 September 2024
Summary:
As of January 23, 2025, TNYA quarterly cash flow from operations is -$19.84 million, with the most recent change of +$3.78 million (+16.01%) on September 30, 2024. Over the past year, it has increased by +$3.80 million (+16.08%). TNYA quarterly CFO is now -172.70% below its all-time high of -$7.27 million, reached on June 1, 2020.TNYA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNYA TTM CFO
-$94.04 M
+$3.80 M+3.89%
30 September 2024
Summary:
As of January 23, 2025, TNYA TTM cash flow from operations is -$94.04 million, with the most recent change of +$3.80 million (+3.89%) on September 30, 2024. Over the past year, it has increased by +$8.79 million (+8.55%). TNYA TTM CFO is now -1041.50% below its all-time high of -$8.24 million, reached on March 31, 2020.TNYA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNYA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.3% | +16.1% | +8.6% |
| 3 y3 years | -188.0% | +16.1% | +8.6% |
| 5 y5 years | -323.6% | +16.1% | +8.6% |
TNYA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -67.8% | +2.3% | -21.3% | +34.5% | -54.6% | +11.9% |
| 5 y | 5-year | -323.6% | +2.3% | -172.7% | +34.5% | -1041.5% | +11.9% |
| alltime | all time | -323.6% | +2.3% | -172.7% | +34.5% | -1041.5% | +11.9% |
Tenaya Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$19.84 M(-16.0%) | -$94.04 M(-3.9%) |
| June 2024 | - | -$23.62 M(-17.6%) | -$97.84 M(-2.6%) |
| Mar 2024 | - | -$28.66 M(+30.7%) | -$100.44 M(-1.6%) |
| Dec 2023 | -$102.07 M(-2.3%) | -$21.92 M(-7.3%) | -$102.07 M(-0.7%) |
| Sept 2023 | - | -$23.64 M(-9.8%) | -$102.83 M(-3.7%) |
| June 2023 | - | -$26.22 M(-13.4%) | -$106.75 M(+0.7%) |
| Mar 2023 | - | -$30.29 M(+33.5%) | -$105.96 M(+1.5%) |
| Dec 2022 | -$104.42 M | -$22.68 M(-17.7%) | -$104.42 M(+6.5%) |
| Sept 2022 | - | -$27.56 M(+8.4%) | -$98.09 M(+12.5%) |
| June 2022 | - | -$25.43 M(-11.6%) | -$87.19 M(+18.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$28.76 M(+75.9%) | -$73.78 M(+21.3%) |
| Dec 2021 | -$60.81 M(+71.6%) | -$16.35 M(-1.9%) | -$60.81 M(+10.8%) |
| Sept 2021 | - | -$16.66 M(+38.6%) | -$54.87 M(+14.9%) |
| June 2021 | - | -$12.02 M(-23.9%) | -$47.74 M(+11.0%) |
| Mar 2021 | - | -$15.79 M(+51.8%) | -$43.00 M(+21.3%) |
| Dec 2020 | -$35.45 M(+47.1%) | - | - |
| Dec 2020 | - | -$10.40 M(+9.1%) | -$35.45 M(+41.5%) |
| Sept 2020 | - | -$9.53 M(+31.1%) | -$25.05 M(+61.5%) |
| June 2020 | - | -$7.27 M(-11.7%) | -$15.51 M(+88.3%) |
| Mar 2020 | - | -$8.24 M | -$8.24 M |
| Dec 2019 | -$24.10 M | - | - |
FAQ
- What is Tenaya Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Tenaya Therapeutics?
- What is Tenaya Therapeutics annual CFO year-on-year change?
- What is Tenaya Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Tenaya Therapeutics?
- What is Tenaya Therapeutics quarterly CFO year-on-year change?
- What is Tenaya Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Tenaya Therapeutics?
- What is Tenaya Therapeutics TTM CFO year-on-year change?
What is Tenaya Therapeutics annual cash flow from operations?
The current annual CFO of TNYA is -$102.07 M
What is the all time high annual CFO for Tenaya Therapeutics?
Tenaya Therapeutics all-time high annual cash flow from operations is -$24.10 M
What is Tenaya Therapeutics annual CFO year-on-year change?
Over the past year, TNYA annual cash flow from operations has changed by +$2.35 M (+2.25%)
What is Tenaya Therapeutics quarterly cash flow from operations?
The current quarterly CFO of TNYA is -$19.84 M
What is the all time high quarterly CFO for Tenaya Therapeutics?
Tenaya Therapeutics all-time high quarterly cash flow from operations is -$7.27 M
What is Tenaya Therapeutics quarterly CFO year-on-year change?
Over the past year, TNYA quarterly cash flow from operations has changed by +$3.80 M (+16.08%)
What is Tenaya Therapeutics TTM cash flow from operations?
The current TTM CFO of TNYA is -$94.04 M
What is the all time high TTM CFO for Tenaya Therapeutics?
Tenaya Therapeutics all-time high TTM cash flow from operations is -$8.24 M
What is Tenaya Therapeutics TTM CFO year-on-year change?
Over the past year, TNYA TTM cash flow from operations has changed by +$8.79 M (+8.55%)